+1-518-621-2074 | US-Canada Toll Free Contact Us

Duramycin Emerged as a New Drug in our Fight Against Spread of Zika Virus from Mom to Fetus

about us

Published on : Jul 20, 2016

Recently, scientists have come out with new insights into how the Zika virus infects the fetus in human beings and have also come out with ways to prevent the same. Zika may pose serious birth defects in the fetus if a woman gets infected with this virus during pregnancy. A large count of babies within Brazil have been found born with extremely small brains and heads, a condition known as microcephaly. Although, according to some studies, only a very few viruses are able to reach to the fetus in case of pregnancy coupled with causing birth defects, still gaining knowledge on how this virus enters is a key question so as to protect the fetus in pregnant mothers.

It has been concluded that Zika is said to infect a number of types of cells within the amniotic sac and placenta and this virus also takes 2 distinct routes for reaching a developing fetus. Researchers have also concluded that an older antibiotic, named duramycin effectively blocks this virus to reborn in the cells that are said to transmit Zika to both of these routes. In previous laboratory research results, duramycin is also said to have fought against West Nile viruses and dengue. These viruses also belong to the similar group of viruses that have Zika.

Duramycin is said to block this infection in numerous placental types. Duramycin also blocks the infection in the fetal membrane cell types that were tested by scientists. These amniotic epithelial and cytotrophoblasts cells and chorionic villus explants.

A lot more research will be needed as how duramycin works against this virus, however, as put by another researcher, duramycin and similar other types of drugs may effectively prevent or lower the risk of transmission of Zika virus to fetus from mother in both potential routes and may also impede the associated birth defects in the fetus.